Exclusive deal with AB for ImageQuant TL

Nonlinear Dynamics and Amersham Biosciences announce further collaboration by signing exclusive software deal for ImageQuant TL™

September 27th 2002 (Newcastle upon Tyne, UK and Piscataway, NJ). Nonlinear Dynamics Ltd announces they have signed an exclusive Software Product Development and Distribution Agreement with Amersham Biosciences for ImageQuant TL. ImageQuant TL is being developed by Nonlinear to continue the existing ImageQuant software, of which there are 10,500 global users.

The new software will be exclusively distributed with all Amersham Biosciences imaging instruments. Used by thousands of scientists, imaging instrumentation is vital for a broad range of life science applications carried out in laboratories worldwide.

Will Dracup, Nonlinear's CEO and Company Founder, said; "This deal further builds the close business relationship we have established with Amersham Biosciences over the last six years." He added; "It also demonstrates Nonlinear's breadth, versatility and expertise throughout the entire field of image analysis and bioinformatics, be it concentrating on 1D electrophoresis, 2D electrophoresis or microarray technology. We feel that this collaboration proves our commitment to all areas of our business, including the extensive 1D market."

John Schneider, Amersham Biosciences' VP of Informatics Marketing added, "Amersham Biosciences is pleased to be broadening our relationship with Nonlinear Dynamics. Our high regard for Nonlinear's capabilities is reflected in this deal to provide the next ImageQuant generation of software."

About Amersham Biosciences

Amersham Biosciences, the life sciences business of Amersham plc (LSE: NYSE: OSE: AHM), is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture. Its systems are used to uncover the function of genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for Amersham Biosciences' products and technologies are pharmaceutical and biotechnology companies and research and academic institutions, principally in North America, Europe, Latin America and Asia. More information about Amersham Biosciences is available at www.amershambiosciences.com.

About Nonlinear Dynamics Ltd

Nonlinear Dynamics develops proteomics analysis software that is different, ground-breaking and above all designed to help you generate reliable conclusions that are reproducible across labs. Our new way of thinking has been applied to LCMS, MALDI and 2D data analysis so you can make a real difference using a combination of the right techniques, your expertise and the Progenesis software. The TotalLab laboratory products for 1D gel analysis provide quick and simple quantitation through to in-depth lane relationship studies, as well as offering features for research that requires 21CFR part 11 compliance.

"Everything about Nonlinear Dynamics makes it a great company to work with..."
Merry L. Lindsey, Ph.D., Assistant Professor
University of Texas Health Science Center at San Antonio

Nonlinear sells and supports its products through its UK headquarters and its USA office, as well as a global network of partners and OEM resellers.

Contact: Beth Rossiter, Marketing Department
Email: beth.rossiter@nonlinear.com
Tel: +44 (0)191 230 2121

Released: 27 September 2002

Current press releases | Archive press releases